Skip to content

Insider · CIK 0001785888

Joakim Wijkstrom

officer

Files at VNDA (Vanda Pharmaceuticals Inc.). First filing Mar 4, 2026, latest Mar 4, 2026.

In brief

Joakim Wijkstrom files SEC Form 4 as officer at VNDA (Vanda Pharmaceuticals Inc.). Since Mar 4, 2026, Joakim Wijkstrom has reported 0 open-market buys worth $0 and 1 open-market sell worth $255k, the latest filed on Mar 4, 2026.

A track record needs three past buys with six months of prices behind them; Joakim Wijkstrom has 0, so none is measured yet.

The newest scored trade: sold $255k of VNDA on Mar 2, 2026, filed Mar 4, 2026, scored 43 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $255k.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $255k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

VNDA: Vanda Pharmaceuticals Inc.

VNDAOct 12, 2026 · close 4.54

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
43Moderate
VNDAsell 6
Vanda Pharmaceuticals Inc.
$255k
30,800 shares
-8%+108% from low-8% from high

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Mar 2, 2026 VNDA
Vanda Pharmaceuticals Inc.
30,800
0.05% of outstanding
$255kMar 2, 2026none

Transactions

Every row this insider has filed, 2 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 2, 2026VNDA
Vanda Pharmaceuticals Inc.
SOpen-market sale
Common Stock
-30,800$8.27$255k333,469Mar 4, 2026
Feb 18, 2026VNDA
Vanda Pharmaceuticals Inc.
AGrant or award
Common Stock
+125,000$0.00$0364,269Feb 19, 2026

Questions about Joakim Wijkstrom

Answered from the filings on this page, as of the latest one.

Is Joakim Wijkstrom buying or selling?

In the last 12 months Joakim Wijkstrom reported 0 open-market buys worth $0 and 1 open-market sell worth $255k on SEC Form 4; the latest was sold $255k of VNDA on Mar 2, 2026. Grants, option exercises and tax withholding are not counted.

How did Joakim Wijkstrom's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Joakim Wijkstrom has 0.

Where does Joakim Wijkstrom file Form 4?

Joakim Wijkstrom has filed Form 4 at VNDA (Vanda Pharmaceuticals Inc.) as SVP, Chief Marketing Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Joakim Wijkstrom: insider trades and track record | InsiderTell